Meda Pharmaceuticals Inc. is the U.S. subsidiary of Meda AB.
Meda Pharmaceuticals specializes in respiratory, allergy, central nervous system, and cough-cold products.
June 2009:
FDA approval for Onsolis anticipated during summer 2009 »
May 2009:
Positive study supporting a potential once-daily nasal antihistamine »
March 2009:
Edluar receives FDA approval »
Meda Pharmaceutical's Philosophy »
Click here to view our Career Opportunities »
Meda Pharmaceutical Inc. supports bona fide educational programs through the provision of educational grants.
Privacy Policy
